Hepatitis A vaccination options for Australia. (Q35072305)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

review article

1 reference

title

Hepatitis A vaccination options for Australia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

0 references

1 reference

M A Burgess

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

B Hull

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

Journal of Paediatrics and Child Health

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

83-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Long-term follow-up of hepatitis A vaccination in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Inactivated hepatitis A vaccine: long-term antibody persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Hepatitis A vaccination during an outbreak among gay men in Montréal, Canada, 1995-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Control of hepatitis A through routine vaccination of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Comparative cost effectiveness of varicella, hepatitis A, and pneumococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Protection against hepatitis A by an inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Changing epidemiology of hepatitis A in the 1990s in Sydney, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Rationale for the infant and adolescent vaccination programmes in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

Prospects for vaccination against hepatitis A and B in Catalonia (Spain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1754.2003.00098.X

10.1046/J.1440-1754.2003.00098.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603793%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference